Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty
A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE Trial)
Gespeichert in:
Verfasser / Beitragende:
[M.B. Preisack, R. Bonan, C. Meisner, V. Eschenfelder, K.R. Karsch]
Ort, Verlag, Jahr:
1998
Enthalten in:
European Heart Journal, 19/8(1998-08-01), 1232-1238
Format:
Artikel (online)
Online Zugang: